Logo image of TUEM

TUESDAY MORNING CORP (TUEM) Stock Fundamental Analysis

NASDAQ:TUEM - Nasdaq - US89904V2007 - Common Stock - Currency: USD

0.685  +0 (+0.16%)

After market: 0.64 -0.05 (-6.57%)

Fundamental Rating

1

Overall TUEM gets a fundamental rating of 1 out of 10. We evaluated TUEM against 28 industry peers in the Broadline Retail industry. TUEM may be in some trouble as it scores bad on both profitability and health. TUEM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TUEM had negative earnings in the past year.
In the past year TUEM has reported a negative cash flow from operations.
TUEM had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TUEM reported negative operating cash flow in multiple years.
TUEM Yearly Net Income VS EBIT VS OCF VS FCFTUEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M -50M -100M -150M

1.2 Ratios

The profitability ratios for TUEM are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TUEM Yearly ROA, ROE, ROICTUEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 -500 -1K -1.5K -2K

1.3 Margins

TUEM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TUEM Yearly Profit, Operating, Gross MarginsTUEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

TUEM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TUEM has been reduced compared to 1 year ago.
Compared to 1 year ago, TUEM has a worse debt to assets ratio.
TUEM Yearly Shares OutstandingTUEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
TUEM Yearly Total Debt VS Total AssetsTUEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 0.27, we must say that TUEM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.27, TUEM is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
TUEM has a Debt/Equity ratio of 11.79. This is a high value indicating a heavy dependency on external financing.
TUEM has a worse Debt to Equity ratio (11.79) than 92.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 11.79
Debt/FCF N/A
Altman-Z 0.27
ROIC/WACCN/A
WACC8.35%
TUEM Yearly LT Debt VS Equity VS FCFTUEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M -100M 200M

2.3 Liquidity

TUEM has a Current Ratio of 1.10. This is a normal value and indicates that TUEM is financially healthy and should not expect problems in meeting its short term obligations.
TUEM has a Current ratio of 1.10. This is in the lower half of the industry: TUEM underperforms 69.23% of its industry peers.
TUEM has a Quick Ratio of 1.10. This is a bad value and indicates that TUEM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.11, TUEM is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.11
TUEM Yearly Current Assets VS Current LiabilitesTUEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

TUEM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -390.39%.
The Revenue for TUEM has decreased by -15.86% in the past year. This is quite bad
Measured over the past years, TUEM shows a decrease in Revenue. The Revenue has been decreasing by -4.95% on average per year.
EPS 1Y (TTM)-390.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.31%
Revenue 1Y (TTM)-15.86%
Revenue growth 3Y-9.37%
Revenue growth 5Y-4.95%
Sales Q2Q%-11.18%

3.2 Future

The Earnings Per Share is expected to grow by 25.48% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.69% on average over the next years.
EPS Next Y98.61%
EPS Next 2Y40.77%
EPS Next 3Y25.48%
EPS Next 5YN/A
Revenue Next Year7.04%
Revenue Next 2Y4.67%
Revenue Next 3Y3.69%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TUEM Yearly Revenue VS EstimatesTUEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
TUEM Yearly EPS VS EstimatesTUEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 10 -10 20 -20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

TUEM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TUEM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TUEM Price Earnings VS Forward Price EarningsTUEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TUEM Per share dataTUEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

A more expensive valuation may be justified as TUEM's earnings are expected to grow with 25.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.77%
EPS Next 3Y25.48%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TUEM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TUESDAY MORNING CORP

NASDAQ:TUEM (12/30/2022, 8:06:53 PM)

After market: 0.64 -0.05 (-6.57%)

0.685

+0 (+0.16%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)09-23 2022-09-23/bmo
Earnings (Next)02-01 2023-02-01
Inst Owners1.25%
Inst Owner Change0%
Ins Owners1692.53%
Ins Owner Change0%
Market Cap4.08M
Analysts43.33
Price Target0.2 (-70.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18920.6%
Min EPS beat(2)-37230.3%
Max EPS beat(2)-610.78%
EPS beat(4)1
Avg EPS beat(4)-10049.6%
Min EPS beat(4)-37230.3%
Max EPS beat(4)105.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.97%
Min Revenue beat(2)-37.53%
Max Revenue beat(2)-16.41%
Revenue beat(4)1
Avg Revenue beat(4)-3.32%
Min Revenue beat(4)-37.53%
Max Revenue beat(4)51.12%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.69
EV/EBITDA N/A
EPS(TTM)-15.89
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-5.4
FCFYN/A
OCF(TTM)-4.38
OCFYN/A
SpS122.7
BVpS0.98
TBVpS0.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.14
Health
Industry RankSector Rank
Debt/Equity 11.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 45.78%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.11
Altman-Z 0.27
F-Score3
WACC8.35%
ROIC/WACCN/A
Cap/Depr(3y)44.01%
Cap/Depr(5y)62.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-390.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.31%
EPS Next Y98.61%
EPS Next 2Y40.77%
EPS Next 3Y25.48%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.86%
Revenue growth 3Y-9.37%
Revenue growth 5Y-4.95%
Sales Q2Q%-11.18%
Revenue Next Year7.04%
Revenue Next 2Y4.67%
Revenue Next 3Y3.69%
Revenue Next 5YN/A
EBIT growth 1Y-38.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.88%
EBIT Next 3Y26.41%
EBIT Next 5YN/A
FCF growth 1Y-126.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-119.39%
OCF growth 3YN/A
OCF growth 5YN/A